Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- HELP for NOWS Consortium
- Study ID
- NCT07278375
- Status
- Recruiting
Conditions
- Neonatal Opioid Withdrawal Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Minutes - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to learn how two medicines used in routine care-buprenorphine and morphine-affect recovery in newborns (≥36 weeks' gestation) with Neonatal Opioid Withdrawal Syndrome (NOWS). The main questions it aims to answer are: 1. Do infants treated with buprenorphine become medically ready for discharge sooner than those treated with morphine? 2. Does one treatment lead to better overall clinical outcomes than the other? Researchers will compare infants who received buprenorphine with infants who received morphine to see whether one treatment helps babies recover more quickly. Participants will not be asked to do anything. Instead, the study team will collect information already documented in the infant's and mother's medical records securely without any contact or changes to clinical care. No new medicines, procedures, or visits are involved. This study only reviews existing clinical data to better understand which commonly used treatment may support faster recovery for newborns with NOWS.
Key Dates
- Start date
- Dec 9, 2025
- Status verified
- Feb 2026
- Primary completion
- Jun 19, 2026
- Completion
- Aug 30, 2026
Study Design
- Enrollment
- 796 participants (estimated)
Arms
- Arm: Infants treated with buprenorphineInfants treated with buprenorphine as the primary opioid for NOWS
- Arm: Infants treated with morphineInfants treated with morphine as the primary opioid for NOWS
Primary Outcome Measure
Time from birth until infant meets criteria for medically ready for discharge (count) [ Time Frame: From date of birth until date of infant meeting criteria for medically ready for discharge (estimated to be < 90 days). ]
Central Contacts
- Walter K Kraft, MD215-955-9077
Locations (22)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | Namasivayam Ambalavanan, MD Namasivayam Ambalavanan, MD (PRINCIPAL_INVESTIGATOR) |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205-7199 | Richard W Hall, MD (PRINCIPAL_INVESTIGATOR) |
| ChristianaCare | Wilmington | Delaware | 19801 | Kelley Z Kovatis, MD (PRINCIPAL_INVESTIGATOR) |
| University of South Florida Health | Tampa | Florida | 33606 | Tanner Wright, MD, FAAP (PRINCIPAL_INVESTIGATOR) |
| Riley Hospital for Children at IU Health | Indianapolis | Indiana | 46202-5119 | Gregory Sokol, MD (PRINCIPAL_INVESTIGATOR) |
| Sidney & Lois Eskenazi Hospital | Indianapolis | Indiana | 46202 | Gregory Sokol, MD (PRINCIPAL_INVESTIGATOR) |
| University of Louisville Hospital | Jeffersonville | Indiana | 47130 | Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR) |
| St. Elizabeth Healthcare | Edgewood | Kentucky | 41017 | Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR) |
| Kentucky Children's Hospital | Lexington | Kentucky | 40536 | Thitinart Sithisarn, MD, PhD, FAAP (PRINCIPAL_INVESTIGATOR) |
| Norton Children's Hospital | Louisville | Kentucky | 40202 | Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR) |
| Norton Women's and Children's Hospital | Louisville | Kentucky | 40207 | Lori Devlin, DO, MHA, MS (PRINCIPAL_INVESTIGATOR) |
| Children's Regional Hospital, Cooper University Health Care | Camden | New Jersey | 08103 | Alla Kushnir, MD, FAAP (PRINCIPAL_INVESTIGATOR) |
| University of New Mexico Health Sciences Center | Albuquerque | New Mexico | 87131 | Lawrence M Leeman, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| University of Rochester Medical Center | Rochester | New York | 14642 | Joseph Bliss, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR) |
| Good Samaritan Hospital | Cincinnati | Ohio | 45202 | Stephanie Merhar, MD, MS (PRINCIPAL_INVESTIGATOR) |
| Rainbow Babies and Children's Hospital | Cleveland | Ohio | 44106 | Moira Crowley, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Scott Lorch, MD, MSCE (PRINCIPAL_INVESTIGATOR) |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | Karen Puopolo, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | Walter K Kraft, MD (PRINCIPAL_INVESTIGATOR) |
| University of Utah Health | Salt Lake City | Utah | 84158 | Bhanu Muniyappa, MD (PRINCIPAL_INVESTIGATOR) |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | Adrienne Pahl, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- MicroRNA Biomarkers for Neonatal Opioid Withdrawal SyndromeRecruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania